Aspen Park Pharmaceuticals
New York, US · Founded 2014 · Delaware corporation
Founders & leadership
Aspen Park Pharmaceuticals was founded in 2014 by Harry Fisch, M.D. and Mitchell S. Steiner.
HF
Harry Fisch, M.D.Chief Corporate Officer
MS
Mitchell S. SteinerChief Executive Officer
HF
Harry Fisch, MDChief Scientific Officer
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 of 2 rounds · 2014–2016
▶$1.3MraisedMar 2016 · 9 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedMar 2016 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Harry Fisch, M.D.Executive Officer, Director
- Mitchell S. SteinerExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.3M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$20MofferedOct 2014 · PharmaceuticalsRule 506(b)
▶$20MofferedOct 2014 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Harry Fisch, MDExecutive Officer, Director
- Mitchell S. SteinerExecutive Officer, Director
- Offering amount
- $20M
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Aspen Park Pharmaceuticals?
- Aspen Park Pharmaceuticals was founded by Harry Fisch, M.D., Mitchell S. Steiner in 2014.
- How much funding has Aspen Park Pharmaceuticals raised?
- Aspen Park Pharmaceuticals has disclosed $1.3M raised across 1 of its 2 known rounds.
- Where is Aspen Park Pharmaceuticals headquartered?
- Aspen Park Pharmaceuticals is headquartered in New York, US.